| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.55 | 0.04 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.33 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |